多重内分泌瘤1型基因映射到11号染色体,在胰岛素瘤中丢失
C Larsson1, B Skogseid, K Oberg
1Department of Clinical Genetics, Karolinska Hospital, Stockholm, Sweden.
Nature
|March 3, 1988
概括
多重内分泌瘤1型 (MEN-1) 是一种遗传性疾病. 遗传研究将MEN-1与染色体11联系起来,揭示了瘤发育过程中被揭露的衰退性突变.
科学领域:
- 遗传学 是一个遗传学.
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
背景情况:
- 多重内分泌瘤1型 (MEN-1) 是一种自体主导的遗传性疾病.
- MEN-1会导致副甲状腺,前垂体和内分泌胰腺的增生.
- 了解MEN-1的遗传基础对于诊断和管理至关重要.
研究的目的:
- 为了绘制 MEN-1 基因位点.
- 为了研究 MEN-1 瘤发生的基因机制.
主要方法:
- 基于家族的遗传联系研究.
- 构造和瘤组织的基因定型.
- 基因标记物的比较,包括人类肌肉酸化酶基因.
主要成果:
- MEN-1位点被映射到染色体11上.
- 证明了与人类肌肉酸化酶基因的紧密联系.
- 在MEN-1中,瘤发生包括在MEN-1位点揭露衰退性突变.
结论:
- MEN-1基因位于11号染色体上.
- 与MEN-1相关的瘤的发展涉及一个双击机制,其中一个衰退性突变被揭露.
相关概念视频
lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...


